title: [Pantogam in the treatment of patients with organic brain lesions of different genesis].
abstract: We studied 35 patients with organic brain lesions caused by secondary brain harmful factors (group 1) and 33 patients with organic brain diseases of vascular genesis (group 2). Mean age of patients was 45.5±2.3 years. Asthenic, cerebroasthenic, psychoorganic syndromes in the combination with dissomnic, psychoautonomous, depressive, hypochondriac disorders predominated in the clinical picture of patients. Pantoham was prescribed in dose 1.0 g 3 times daily during 45 days. The effect of the drug on cognitive and mental disorders was found. The drug was most effective in patients of group 1. Pantoham was well-tolerated.
authors.affiliation: Klinika ékzogenno-organicheskikh rasstroĭstv i épilepsii.
authors.forename: T A
authors.initials: TA
authors.lastname: Rogacheva
authors.forename: T S
authors.initials: TS
authors.lastname: Mel'nikova
authors.forename: L A
authors.initials: LA
authors.lastname: Krasnoslobodtseva
authors.forename: D M
authors.initials: DM
authors.lastname: Nazmetdinova
authors.forename: I A
authors.initials: IA
authors.lastname: Lapin
mesh_terms: D000328:Adult; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D018697:Nootropic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010205:Pantothenic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D018697:Nootropic Agents; C016030:pantogab; D010205:Pantothenic Acid; D005680:gamma-Aminobutyric Acid